SCHEMBL16291371

SCHEMBL16291371

CCOC(=O)CNC(=O)CSC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.53
PPID Q08752 1/20 0.51
POLB P06746 2/20 0.49
RXFP1 Q9HBX9 2/20 0.49
GAA P10253 2/20 0.49
HPGD P15428 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
TSHR P16473 1/20 0.47
TP53 P04637 2/20 0.47
PRNP P04156 1/20 0.46
ATM Q13315 1/20 0.45
ALOX15 P16050 1/20 0.45
KDM4E B2RXH2 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1143585 0.85 SMN1; SMN2 (0.48) ALDH1A1PPIDPOLBRXFP1L3MBTL1
SCHEMBL10503169 0.82 KIF11 (0.42)
SCHEMBL16291478 0.82 KIF11 (0.42) ALDH1A1
SCHEMBL9373019 0.80 ALDH1A1 (0.61) ALDH1A1PPIDPOLBRXFP1GAA
SCHEMBL13177607 0.80 KIF11 (0.44)
SCHEMBL14401044 0.78 MEN1 (0.37) ALDH1A1POLBMEN1KMT2AKDM4E
SCHEMBL23956928 0.77 KIF11 (0.58) ALDH1A1GAAHPGDMEN1KMT2A
SCHEMBL17245967 0.76 KIF11 (0.43) ALDH1A1HPGDSMN1; SMN2RAB9ANPC1
SCHEMBL6574289 0.76 KIF11 (0.43) POLBRXFP1
SCHEMBL1364085 0.76 KIF11 (0.49) ALDH1A1POLBRXFP1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9044519-B2 Radiotracer precursor for imaging of hypoxic tissue, radiotracer, and method for preparing the same Atomic Energy Council—Institute of Nuclear Energy Research (TW) 2015-06-02 US claimed
US-20140371434-A1 RADIOTRACER PRECURSOR FOR IMAGING OF HYPOXIC TISSUE, RADIOTRACER, AND METHOD FOR PREPARING THE SAME ATOMIC ENERGY COUNCIL-INSTTITUTE OF NUCLEAR ENERGY RESEARCH (TW) 2014-12-18 US claimed
US-9044519-B2 Radiotracer precursor for imaging of hypoxic tissue, radiotracer, and method for preparing the same Atomic Energy Council—Institute of Nuclear Energy Research (TW) 2015-06-02 US disclosed
US-9044519-B2 Radiotracer precursor for imaging of hypoxic tissue, radiotracer, and method for preparing the same Atomic Energy Council—Institute of Nuclear Energy Research (TW) 2015-06-02 US disclosed
US-20140371434-A1 RADIOTRACER PRECURSOR FOR IMAGING OF HYPOXIC TISSUE, RADIOTRACER, AND METHOD FOR PREPARING THE SAME ATOMIC ENERGY COUNCIL-INSTTITUTE OF NUCLEAR ENERGY RESEARCH (TW) 2014-12-18 US disclosed
US-20140371434-A1 RADIOTRACER PRECURSOR FOR IMAGING OF HYPOXIC TISSUE, RADIOTRACER, AND METHOD FOR PREPARING THE SAME ATOMIC ENERGY COUNCIL-INSTTITUTE OF NUCLEAR ENERGY RESEARCH (TW) 2014-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371434-A1 RADIOTRACER PRECURSOR FOR IMAGING OF HYPOXIC TISSUE, RADIOTRACER, AND METHOD FOR PREPARING THE SAME HIF1A, HIF1AN, HYOU1 ALDH1A1 528/4885PPID 2119/4885POLB 2920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.